CRNX
Crinetics Pharmaceuticals, Inc. ยท Health Care ยท NASDAQ
$35.38
โผ $0.49 (โ1.37%)
Market cap
$3.8B
52-week range
$25.83 โ $57.99
Volume
964K
Previous close
$35.87
Crinetics Pharmaceuticals, Inc. (CRNX) is held by 4 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: Driehaus Capital Management LLC.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Driehaus Capital Management LLC Driehaus Capital Management LLC |
1.7% | 6.4M | $232M | โ | $16.06 | 2026-03-31 |
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.5% | 2.4M | $85M | โฒ 43% (+703K) | $44.79 | 2026-03-31 |
| RTW INVESTMENTS, LP RTW INVESTMENTS, LP |
0.5% | 1.5M | $53M | โฒ 7.4% (+100K) | $28.76 | 2026-03-31 |
| ORBIMED ADVISORS LLC ORBIMED ADVISORS LLC |
0.7% | 999K | $36M | โ | $16.06 | 2026-03-31 |
FAQ โพ
Which hedge funds hold CRNX?
Tracked holders include: Driehaus Capital Management LLC, BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC.
How much smart money owns CRNX?
4 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading CRNX?
No tracked Congressional trades in CRNX on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.